Global Drug Eluting Stents (DES) Market By Coating (Polymer Based Coating, Biodegradable, Non-biodegradable, Polymer Free Coating, Microporous Surface, Microstructured Surface, Slotted Tubular Surface, Nanoporous Surface), End-Users (Hospitals, Cardiology Centers, Ambulatory Surgical Centers), Application (Coronary Artery Disease, Peripheral Artery Disease), Drug (Sirolimus, Pactitaxel, Zotarolimus, Everolimus, Biolimus, Others), Generation (1st Generation, 2nd Generation, 3RD Generation, 4TH Generation), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027
Market Analysis and Insights of Global Drug Eluting Stents (DES) Market
Drug eluting stents (DES) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 9.20 billion by 2027 growing at a CAGR of 5.35% in the above-mentioned forecast period. Increasing cases of arterial diseases is expected to create new opportunity for the market.
A drug-eluting stent is a stent that is inserted in narrowed peripheral or coronary arteries that slowly raise a drug to inhibit the replication of cells. Drug-eluting stents are more preferred than bare metal stents to prevent the blockage from repeating.
Increasing cases of cardiovascular diseases is expected to enhance the market growth. Some of the factors such as rising ageing population, growing popularity of minimally invasive endovascular surgeries, increasing usage of DES for the treatment of atherosclerosis, technological advancement and favourable reimbursement policy is expected to enhance the drug eluting stents (DES) market in the forecast period of 2020 to 2027.
Dearth of skilled professionals, strict regulatory approvals, and risk associated with thrombosis and disruption will hamper the market growth in the mentioned forecast period.
This drug eluting stents (DES) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research drug eluting stents (DES) market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Drug Eluting Stents (DES) Market Scope and Market Size
Drug eluting stents (DES) market is segmented of the basis of coating, end-users, drug, generation and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of coating, the drug eluting stents (DES) market is segmented into polymer based coating, biodegradable, non-biodegradable, polymer free coating, microporous surface, microstructured surface, slotted tubular surface and nanoporous surface.
- Based on end- users, the drug eluting stents (DES) market is segmented into hospitals, cardiology centers and ambulatory surgical centers.
- The application segment of the drug eluting stents (DES) market is divided into coronary artery disease and peripheral artery disease.
- On the basis of drugs, the drug eluting stents (DES) market is segmented into sirolimus, pactitaxel, zotarolimus, everolimus, biolimus and others.
- Based on generation, the drug eluting stents (DES) market is segmented into 1st Generation, 2nd Generation, 3RD Generation, and 4TH Generation.
Drug Eluting Stents (DES) Market Country Level Analysis
Drug eluting stents (DES) market is analysed and market size insights and trends are provided by coating, end-users, drug, generation and application as referenced above.
The countries covered in the drug eluting stents (DES) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the drug eluting stents (DES) market in the forecast period of 2020 to 2027 due to favourable reimbursement policies and strict rules & norms for medical device manufacturing. Asia-Pacific is expected to be the fastest growing region due to improvement in healthcare infrastructure and increasing healthcare spending.
The country section of the drug eluting stents (DES) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Drug eluting stents (DES) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for drug eluting stents (DES) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the drug eluting stents (DES) market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Drug Eluting Stents (DES) Market Share Analysis
Drug eluting stents (DES) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to drug eluting stents (DES) market.
The major players covered in the drug eluting stents (DES) market report Abbott, B. Braun Melsungen AG, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Terumo Corporation, Medtronic, MicroPort Scientific Corporation, ORBUSNEICH MEDICAL, Relisys Medical Devices Limited, REVA Medical Inc., Sino Medical Sciences Technology Inc., STENTYS SA, lepumedical.com., Cook, HEXACATH, Cardinal Health among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Drug Eluting Stents (DES) Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.